Abstract
LINC00184 has been suggested to be associated with cancer prognosis and has been implicated in cancer glycolysis; however, its role in oesophageal squamous cell carcinoma (ESCC) remains poorly understood. Herein, to understand the expression and the biological roles of LINC00184 in ESCC, in situ hybridization (ISH) and quantitative PCR (qPCR) were performed to detect the expression of LINC00184 in tissue blocks and in fresh tissues, respectively. Furthermore, with an in vitro cell culture system, LINC00184 was stably knocked down in ESCC cell lines KYSE-150 and Eca109, followed by determining alterations in their proliferation and motility relative to control. To gain insight into the regulation of LINC00184, STAT3 was bioinformatically identified as a transcription factor of LINC00184, which was further corroborated by chromatin-immunoprecipitation (CHIP) assay. The dephosphorylation of STAT3 with NSC74859 was shown to be unable to suppress the expression of LINC00184 in vivo in a xenograft mouse model. Moreover, STAT3, once phosphorylated at serine 727, tended to translocate into the mitochondria to promote LINC00184 expression in ESCC cells. Together, these data strongly support the oncogenic role of LINC00184 in ESCC.
Similar content being viewed by others
Data availability
The datasets analyzed in this study are available in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) public repository.
References
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
Chen D, Fan N, Mo J, Wang W, Wang R, Chen Y, Hu J, Wen Z (2019) Multiple primary malignancies for squamous cell carcinoma and adenocarcinoma of the esophagus. J Thorac Dis 11:3292–3301. https://doi.org/10.21037/jtd.2019.08.51
Zeng H, Zheng R, Zhang S, Zuo T, Xia C, Zou X, Chen W (2016) Esophageal cancer statistics in China, 2011: estimates based on 177 cancer registries. Thorac Cancer 7:232–237. https://doi.org/10.1111/1759-7714.12322
Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M (2019) Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 16:1–24. https://doi.org/10.1007/s10388-018-0641-9
Ohkura Y, Ueno M, Iizuka T, Udagawa H (2019) Prognostic factors and appropriate lymph node dissection in salvage esophagectomy for locally advanced T4 esophageal cancer. Ann Surg Oncol 26:209–216. https://doi.org/10.1245/s10434-018-7074-5
Weidle UH, Birzele F, Kollmorgen G, Ruger R (2017) Long non-coding RNAs and their role in metastasis. Cancer Genomics Proteomics 14:143–160. https://doi.org/10.21873/cgp.20027
Fidler IJ (2003) The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer 3:453–458. https://doi.org/10.1038/nrc1098
Li W, Huang K, Wen F, Cui G, Guo H, He Z, Zhao S (2019) LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN. EBioMedicine 44:298–310. https://doi.org/10.1016/j.ebiom.2019.05.055
Yao Y, Zhang T, Qi L, Zhou C, Wei J, Feng F, Liu R, Sun C (2019) Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer. J Cell Mol Med. https://doi.org/10.1111/jcmm.14721
Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu DY, Tang CJ, De W, Yang F (2018) STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer 17:6. https://doi.org/10.1186/s12943-017-0756-y
Liu Z, Li H, Fan S, Lin H, Lian W (2019) STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Cancer Biol Ther 20:444–453. https://doi.org/10.1080/15384047.2018.1529119
Liang C, Zhao T, Li H, He F, Zhao X, Zhang Y, Chu X, Hua C, Qu Y, Duan Y, Ming L, Guo J (2019) Long non-coding RNA ITIH4-AS1 accelerates the proliferation and metastasis of colorectal cancer by activating JAK/STAT3 signaling. Mol Ther Nucleic Acids 18:183–193. https://doi.org/10.1016/j.omtn.2019.08.009
Kamran MZ, Patil P, Gude RP (2013) Role of STAT3 in cancer metastasis and translational advances. Biomed Res Int 2013:421821. https://doi.org/10.1155/2013/421821
Zhang X, Sun Y, Pireddu R, Yang H, Urlam MK, Lawrence HR, Guida WC, Lawrence NJ, Sebti SM (2013) A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation. Cancer Res 73:1922–1933. https://doi.org/10.1158/0008-5472.CAN-12-3175
Avalle L, Camporeale A, Morciano G, Caroccia N, Ghetti E, Orecchia V, Viavattene D, Giorgi C, Pinton P, Poli V (2019) STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca (2+) fluxes and apoptotic responses. Cell Death Differ 26:932–942. https://doi.org/10.1038/s41418-018-0171-y
Carballo M, Conde M, El Bekay R, Martin-Nieto J, Camacho MJ, Monteseirin J, Conde J, Bedoya FJ, Sobrino F (1999) Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 274:17580–17586. https://doi.org/10.1074/jbc.274.25.17580
Garama DJ, White CL, Balic JJ, Gough DJ (2016) Mitochondrial STAT3: powering up a potent factor. Cytokine 87:20–25. https://doi.org/10.1016/j.cyto.2016.05.019
Avalle L, Poli V (2018) Nucleus, mitochondrion, or reticulum? STAT3 a la carte. Int J Mol Sci. https://doi.org/10.3390/ijms19092820
Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M, Baranasic D, Santana-Garcia W, Tan G, Cheneby J, Ballester B, Parcy F, Sandelin A, Lenhard B, Wasserman WW, Mathelier A (2020) JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 48:D87–D92. https://doi.org/10.1093/nar/gkz1001
Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91–D94. https://doi.org/10.1093/nar/gkh012
Zhu S, Wang Z, Zhang Z, Wang J, Li Y, Yao L, Mei Q, Zhang W (2014) PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis. FEBS Lett 588:981–989. https://doi.org/10.1016/j.febslet.2014.01.058
Qi C, Han T, Tang H, Huang K, Min J, Li J, Ding X, Xu Z (2017) Shp2 inhibits proliferation of esophageal squamous cell cancer via dephosphorylation of Stat3. Int J Mol Sci. https://doi.org/10.3390/ijms18010134
Sugase T, Takahashi T, Serada S, Fujimoto M, Hiramatsu K, Ohkawara T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Kishimoto T, Mori M, Doki Y, Naka T (2017) SOCS1 gene therapy improves radiosensitivity and enhances irradiation-induced DNA damage in esophageal squamous cell carcinoma. Cancer Res 77:6975–6986. https://doi.org/10.1158/0008-5472.CAN-17-1525
Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, Zasloff M, Marshall JL, Shetty K, Johnson L, Mishra L, He AR (2009) The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 28:961–972. https://doi.org/10.1038/onc.2008.448
Bu LL, Li YC, Yu GT, Liu JF, Deng WW, Zhang WF, Zhang L, Sun ZJ (2017) Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model. Sci Rep 7:6629. https://doi.org/10.1038/s41598-017-06643-9
Zhang Q, Raje V, Yakovlev VA, Yacoub A, Szczepanek K, Meier J, Derecka M, Chen Q, Hu Y, Sisler J, Hamed H, Lesnefsky EJ, Valerie K, Dent P, Larner AC (2013) Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem 288:31280–31288. https://doi.org/10.1074/jbc.M113.505057
Chen W, Shen X, Xia X, Xu G, Ma T, Bai X, Liang T (2012) NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma. Liver Int 32:70–77. https://doi.org/10.1111/j.1478-3231.2011.02631.x
Tammineni P, Anugula C, Mohammed F, Anjaneyulu M, Larner AC, Sepuri NB (2013) The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem 288:4723–4732. https://doi.org/10.1074/jbc.M112.378984
Funding
This work was supported by the National Science Foundation of China (Grant No. 82073084).
Author information
Authors and Affiliations
Contributions
YX and SLL were the principal investigators who designed and conceived the study and obtained financial support. CLJ and HQ analyzed the data and wrote the manuscript. CLJ and HQ prepared the dataset. All authors have read, revised, and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
This research project was approved by the Ethics Committee of Peking Union Medical College Hospital. Written consents were obtained from each patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jin, C., Qi, H., Xu, Y. et al. Serine 727 phosphorylation is necessary to induce the STAT3-mediated transcription of LINC00184 in oesophageal squamous cell carcinoma. Mol Cell Biochem 477, 1775–1787 (2022). https://doi.org/10.1007/s11010-022-04405-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-022-04405-4